Xylem (XYL) Stock Climbs as First Quarter Earnings Exceed Forecasts

Quick Summary

Table of Contents

Xylem delivered Q1 earnings per share of $1.12, surpassing Wall Street’s $1.09 projection
Quarterly revenue reached $2.1 billion, falling just short of the $2.11 billion forecast
Order intake reached $2.2 billion, representing a 3% year-over-year increase
Company lifted full-year 2026 revenue projections to $9.2B–$9.3B range
Shares climbed 1.6% in premarket activity before Tuesday’s market open

Xylem unveiled a somewhat mixed yet overall encouraging first-quarter performance on Tuesday morning, delivering bottom-line results that topped analyst projections despite falling marginally short on the revenue front.

$XYL Q1 2026 earnings: Steady Margins Mask a Stagnant Top Line
Xylem delivered a technically solid but uninspiring first quarter. Revenue and orders were completely flat organically (0% growth), absorbing the intentional headwinds from management's ongoing 80/20 portfolio…
— Finsee (@Finsee_main) April 28, 2026

The water infrastructure and technology specialist posted adjusted earnings of $1.12 per share for the opening quarter, eclipsing the Street consensus estimate of $1.09. This represents a notable improvement from the $1.03 per share recorded in the prior-year period.

Quarterly revenue totaled $2.1 billion, reflecting a 3% year-over-year advance on a reported basis. On an organic basis—which excludes the impact of foreign exchange fluctuations and merger-and-acquisition activity—revenue remained essentially unchanged. Wall Street had anticipated $2.11 billion, making this a narrow top-line shortfall.

Xylem Inc., XYL

Incoming orders totaled $2.2 billion, marking a 3% reported increase versus the year-ago quarter, although staying flat organically. The fact that order momentum is outpacing revenue growth typically signals positive near-term business prospects.

Adjusted EBITDA margin improved by 20 basis points year over year, reaching 20.6%. The company attributed this expansion to efficiency improvements and favorable pricing dynamics, which successfully counterbalanced inflationary pressures and somewhat weaker volume trends.

Chief Executive Matthew Pine adopted a cautiously optimistic stance. “We began the year with continued momentum and healthy demand across important end markets,” he commented. “Though the external landscape remains fluid, our organization is performing effectively, maintaining close customer relationships, and pursuing strategic long-term objectives.”

Full-Year Outlook Receives Upward Revision

Xylem elevated its full-year 2026 revenue forecast modestly. Management now anticipates revenue between $9.2 billion and $9.3 billion, an increase from the previous guidance range of $9.1 billion to $9.2 billion. This projection implies reported growth of 2% to 3%.

The full-year adjusted earnings per share guidance remained unchanged at $5.35 to $5.60. The range’s midpoint of $5.48 falls slightly below the analyst consensus projection of $5.49.

Management also forecasts full-year adjusted EBITDA margin in the 22.9% to 23.3% range, which would mark an expansion of 70 to 110 basis points compared to 2025 performance.

Jefferies analyst Stephen Volkmann characterized the quarterly performance as “in line.” While not an overwhelmingly positive assessment, market participants appeared to view the results as satisfactory.

Stock Performance Analysis

Xylem shares advanced 1.6% in premarket action, reaching $125.50, even as broader index futures showed modest weakness.

Heading into Tuesday’s session, XYL had declined 9% on a year-to-date basis and gained only 6% over the trailing twelve-month period. The stock experienced an 8% decline following its fourth-quarter earnings release in February.

First-quarter reported earnings per share came to $0.79, up 14% from the $0.69 figure in the comparable prior-year quarter.

The first-quarter results appear to have at least temporarily halted the stock’s recent decline.